500 related articles for article (PubMed ID: 25666998)
1. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.
Toblli JE; Di Gennaro F; Rivas C
Heart Lung Circ; 2015 Jul; 24(7):686-95. PubMed ID: 25666998
[TBL] [Abstract][Full Text] [Related]
2. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
3. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.
Beck-da-Silva L; Piardi D; Soder S; Rohde LE; Pereira-Barretto AC; de Albuquerque D; Bocchi E; Vilas-Boas F; Moura LZ; Montera MW; Rassi S; Clausell N
Int J Cardiol; 2013 Oct; 168(4):3439-42. PubMed ID: 23680589
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
Usmanov RI; Zueva EB; Silverberg DS; Shaked M
J Nephrol; 2008; 21(2):236-42. PubMed ID: 18446719
[TBL] [Abstract][Full Text] [Related]
5. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial.
Perelló MF; Coloma JL; Masoller N; Esteve J; Palacio M
BJOG; 2014 May; 121(6):706-13. PubMed ID: 24423186
[TBL] [Abstract][Full Text] [Related]
6. Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency.
Reed BN; Blair EA; Thudium EM; Waters SB; Sueta CA; Jensen BC; Rodgers JE
Pharmacotherapy; 2015 Jan; 35(1):64-71. PubMed ID: 25556867
[TBL] [Abstract][Full Text] [Related]
7. Ferric carboxymaltose in patients with heart failure and iron deficiency.
Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
[TBL] [Abstract][Full Text] [Related]
9. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
Block GA; Fishbane S; Rodriguez M; Smits G; Shemesh S; Pergola PE; Wolf M; Chertow GM
Am J Kidney Dis; 2015 May; 65(5):728-36. PubMed ID: 25468387
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of intravenous and oral iron in chronic kidney disease.
Agarwal R; Kusek JW; Pappas MK
Kidney Int; 2015 Oct; 88(4):905-14. PubMed ID: 26083656
[TBL] [Abstract][Full Text] [Related]
11. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
Onken JE; Bregman DB; Harrington RA; Morris D; Buerkert J; Hamerski D; Iftikhar H; Mangoo-Karim R; Martin ER; Martinez CO; Newman GE; Qunibi WY; Ross DL; Singh B; Smith MT; Butcher A; Koch TA; Goodnough LT
Nephrol Dial Transplant; 2014 Apr; 29(4):833-42. PubMed ID: 23963731
[TBL] [Abstract][Full Text] [Related]
12. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.
Cunha GJL; Rocha BML; Menezes Falcão L
Eur J Intern Med; 2018 Jun; 52():1-7. PubMed ID: 29680173
[TBL] [Abstract][Full Text] [Related]
13. Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease.
Moorani KN; Asim S
J Ayub Med Coll Abbottabad; 2011; 23(3):47-50. PubMed ID: 23272434
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
[TBL] [Abstract][Full Text] [Related]
15. Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design.
Miñana G; Cardells I; Palau P; Llàcer P; Fácila L; Almenar L; López-Lereu MP; Monmeneu JV; Amiguet M; González J; Serrano A; Montagud V; López-Vilella R; Valero E; García-Blas S; Bodí V; de la Espriella-Juan R; Sanchis J; Chorro FJ; Bayés-Genís A; Núñez J;
Clin Cardiol; 2018 Jun; 41(6):729-735. PubMed ID: 29607528
[TBL] [Abstract][Full Text] [Related]
16. Oral or intravenous iron for anemia correction in chronic kidney disease?
Drüeke TB; Massy ZA
Kidney Int; 2015 Oct; 88(4):673-5. PubMed ID: 26422625
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial.
Goldstein SL; Morris D; Warady BA
Am J Kidney Dis; 2013 Apr; 61(4):588-97. PubMed ID: 23245582
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure.
McCullough PA; Uhlig K; Neylan JF; Pergola PE; Fishbane S
Am J Cardiol; 2018 Aug; 122(4):683-688. PubMed ID: 29961562
[TBL] [Abstract][Full Text] [Related]
19. A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status.
Bhandari S; Allgar V; Lamplugh A; Macdougall I; Kalra PA
BMC Nephrol; 2021 Mar; 22(1):115. PubMed ID: 33784968
[TBL] [Abstract][Full Text] [Related]
20. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
Wikström B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL
J Nephrol; 2011; 24(5):589-96. PubMed ID: 21240875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]